PITTSBURGH- Oct. 2 /PRNewswire-FirstCall/ -- Mylan (NYSE: MYL)
announced today that it has completed its acquisition of Merck
KGaA's generics business ("Merck Generics") to become one of the
largest quality generics and specialty pharmaceuticals companies in
the world. Mylan and Merck KGaA initially announced the signing of
a definitive agreement under which Mylan would acquire Merck
Generics for EUR 4.9 billion ($6.8 billion) in an all-cash
transaction on May 12- 2007.